Pulse Biosciences Reports Third-Quarter 2026 Financial Results and Business Updates
Pulse Biosciences reported financial results for the quarter ended September 30, 2026. The supplied body is truncated before providing figures or further details.
Pulse Biosciences, Inc. (NASDAQ:PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced business updates and financial results for the third quarter ended September 30, 2026.“Pulse Biosciences delivered…